Amphetamine Use Disorder
📧 Sign up to get email alerts when something new happens for Amphetamine Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder [Phase 1, Phase 2]
This document reports a Phase 1/2 clinical trial evaluating psilocybin-enhanced psychotherapy for methamphetamine use disorder. The broader …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: tTIS Targeted of the Striatum as an Intervention for MUD Patients [NA]
This clinical trial update describes a study evaluating targeted tTIS of the striatum for amphetamine use disorders, with recruitment not ye…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Individualized Neuromodulation for the Core Clinical Features of Drug Addiction [NA]
A completed clinical trial evaluated individualized neuromodulation for the core features of drug addiction in amphetamine use disorder. The…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Closed-loop tACS Modulation for the Core Clinical Features of Drug Addiction [NA]
The clinical trial evaluating closed-loop transcranial alternating current stimulation (tACS) to modulate core features of amphetamine use d…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Effects of Repetitive Transcranial Magnetic Stimulations in Patients With Amphetamine Use Disorders [NA]
Clinical trial listing for the effects of repetitive transcranial magnetic stimulation (rTMS) in patients with amphetamine use disorder; the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Role of Pavlovian Mechanisms for Control Over Substance Use
An ongoing study from Technische Universität Dresden is exploring Pavlovian mechanisms for controlling substance use, with recruitment under…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Closed-loop cTBS for the Core Clinical Features of Methamphetamine Use Disorder [NA]
This clinical trial assesses closed-loop transcranial magnetic stimulation (cTBS) for core symptoms of methamphetamine use disorder, sponsor…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Hospital-Based Contingency Management [NA]
A ClinicalTrials.gov update indicates a hospital-based contingency management study for amphetamine use disorder is currently enrolling by i…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1 [Phase 1]
Phase 1 trial update evaluating the safety and tolerability of sublingual lobeline at 7.5, 15, and 30 mg in individuals with amphetamine-rel…
-
CLINICAL_TRIALS research · 2017-01-11Clinical Trial Update: Effects of Stimulant Dependence on Human Striatal Dopamine System - 15 [Phase 1]
A Phase 1 clinical trial update examining the effects of stimulant dependence on the human striatal dopamine system; the current status is u…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Conflict Between Maternal Autonomy and Child Health in Substance-use
This completed clinical trial update examines the balance between maternal autonomy and neonatal health in the setting of substance use duri…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Mephedrone and Alcohol Interactions in Humans [Phase 1]
Phase 1 study evaluating interactions between mephedrone and alcohol in humans has been completed.
-
CLINICAL_TRIALS research · 2015-09-04Clinical Trial Update: An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS Dependence [Phase 3]
An open-label Phase 3 trial is evaluating oral minocycline for individuals with co-occurring opioid (heroin) and amphetamine dependence. The…
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence [Phase 3]
An open-label Phase 3 trial evaluating paliparidone for co-occurring opioid use disorder (heroin dependence) and amphetamine use disorder; c…
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers [Phase 1]
Phase 1 trial evaluating the safety and tolerability of varenicline in methamphetamine-dependent volunteers.
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence [NA]
This pilot trial evaluates citicoline as an add-on therapy for patients with bipolar disorder or major depressive disorder who also have amp…
-
CLINICAL_TRIALS trial_result · 2011-12-15Clinical Trial Update: Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging [NA]
A completed University of Zurich clinical trial examined serotonin neurotransmission in MDMA users using a dexfenfluramine challenge with PE…
-
CLINICAL_TRIALS trial_result · 2009-06-15Clinical Trial Update: Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine) [Phase 1]
A Phase 1 trial from University Hospital Basel examined the pharmacological interaction between pindolol and MDMA across mood disorders and …
-
CLINICAL_TRIALS trial_result · 2007-11-05Clinical Trial Update: Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories [Phase 2]
A Phase 2 safety, tolerability, and abuse-liability study of intravenous NRP104 in adults with stimulant-use histories has been completed.
-
CLINICAL_TRIALS trial_result · 2007-11-05Clinical Trial Update: Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating the abuse potential, safety, and likeability of NRP 104 in adults with histories of stimulant use.